KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E Adjustments
Ratios

TherapeuticsMD (TXMD) Long-Term Debt Repayments (2021 - 2022)

Historic Long-Term Debt Repayments for TherapeuticsMD (TXMD) over the last 5 years, with Q4 2022 value amounting to $94.4 million.

  • TherapeuticsMD's Long-Term Debt Repayments changed N/A to $94.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $219.4 million, marking a year-over-year increase of 33886.4%. This contributed to the annual value of $219.4 million for FY2022, which is 33886.4% up from last year.
  • According to the latest figures from Q4 2022, TherapeuticsMD's Long-Term Debt Repayments is $94.4 million.
  • TherapeuticsMD's 5-year Long-Term Debt Repayments high stood at $120.0 million for Q2 2022, and its period low was $5.0 million during Q1 2022.